Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Program Coordinator: Laura Kasman, Ph.D. [email_address]
M&I program currently <ul><li>17 Ph.D. students </li></ul><ul><li>4 MD/Ph.D. students </li></ul><ul><li>1 DMD/Ph.D. studen...
Program Requirements <ul><li>6 credits in advanced M&I courses in 2nd year </li></ul><ul><li>Written qualifying exam, summ...
M&I Advanced course offerings
Departmental vs. Program Faculty <ul><li>Department Faculty have M&I as their home department </li></ul><ul><li>M&I Progra...
M&I Department Faculty Interests
Bacteriologists <ul><li>Michael Schmidt  Hal May   Ed Balish </li></ul>
Virologists <ul><li>Natalie Sutkowski  John Y. Dong  Laura Kasman </li></ul>
Immunologists <ul><li>Janardan  Stephen  Gabriel  Aziz  Carl </li></ul><ul><li>Pandey  Tomlinson  Virella  Haque  Atkinson...
Tumor Immunologists &  Gene Therapy <ul><li>James Norris  Christina  Xiang Liu  Semyon </li></ul><ul><li>  Voelkel-Johnson...
Program Faculty <ul><li>Surgery </li></ul><ul><li>Prabhakar Baliga </li></ul><ul><li>Mike Nishimura </li></ul><ul><li>Kenn...
Program Faculty <ul><li>College of Dental Medicine </li></ul><ul><li>Robert Boackle </li></ul><ul><li>Caroline Westwater <...
Entrepreneurship by M&I faculty Bacterial electricity generation, Microbial fuel cells Dr. May MFC Tech Therapeutic comple...
MOUNT PLEASANT, SC (AUGUST 30, 2007) - Groundbreaking ceremony for new facility at Innovation Park, in the economic develo...
James S. Norris, PhD Co-Founder, SphingoGene, Inc.  http://www.sphingogene.com Professor and Chairman, MUSC [email_address...
Controlling Inflammation to Treat Human Disease Applying novel technologies to create better treatments Contact:   Woodruf...
Dr. Hal May, Ph.D. VP, MFC Technologies LLC http://www. mfctech .net hmay @ mfctech .net   Assoc. Prof. MUSC mayh @ musc ....
<ul><li>MFC Tech is focused on the development of microbial fuel cell technology  (MFCs),  which utilizes the ability of b...
Upcoming SlideShare
Loading in …5
×

Microbiology and Immunology

1,344 views

Published on

Published in: Health & Medicine
  • Be the first to comment

Microbiology and Immunology

  1. 1. Program Coordinator: Laura Kasman, Ph.D. [email_address]
  2. 2. M&I program currently <ul><li>17 Ph.D. students </li></ul><ul><li>4 MD/Ph.D. students </li></ul><ul><li>1 DMD/Ph.D. student </li></ul><ul><li>2 Masters students </li></ul><ul><li>15 Departmental faculty </li></ul><ul><li>40 Total Program faculty </li></ul>
  3. 3. Program Requirements <ul><li>6 credits in advanced M&I courses in 2nd year </li></ul><ul><li>Written qualifying exam, summer after 2nd year </li></ul><ul><li>Thesis proposal defense, usually sometime in 3rd year for admission to candidacy </li></ul><ul><li>12 advanced credits total, not including M&I Seminar </li></ul>
  4. 4. M&I Advanced course offerings
  5. 5. Departmental vs. Program Faculty <ul><li>Department Faculty have M&I as their home department </li></ul><ul><li>M&I Program Faculty can be faculty members from any MUSC department that have research interests related to microbiology or immunology </li></ul><ul><li>Faculty can be affiliated with more than one graduate program </li></ul>
  6. 6. M&I Department Faculty Interests
  7. 7. Bacteriologists <ul><li>Michael Schmidt Hal May Ed Balish </li></ul>
  8. 8. Virologists <ul><li>Natalie Sutkowski John Y. Dong Laura Kasman </li></ul>
  9. 9. Immunologists <ul><li>Janardan Stephen Gabriel Aziz Carl </li></ul><ul><li>Pandey Tomlinson Virella Haque Atkinson </li></ul><ul><li>Also Natalie Sutkowski </li></ul>
  10. 10. Tumor Immunologists & Gene Therapy <ul><li>James Norris Christina Xiang Liu Semyon </li></ul><ul><li> Voelkel-Johnson Rubinchik </li></ul><ul><li>Also Stephen Tomlinson & John Dong </li></ul>
  11. 11. Program Faculty <ul><li>Surgery </li></ul><ul><li>Prabhakar Baliga </li></ul><ul><li>Mike Nishimura </li></ul><ul><li>Kenneth Chavin </li></ul><ul><li>David Cole </li></ul><ul><li>Yi Zhang </li></ul><ul><li>Pathology </li></ul><ul><li>Amanda LaRue </li></ul><ul><li>Otolaryngology </li></ul><ul><li>Rita Young </li></ul><ul><li>Neurosciences/Neurology </li></ul><ul><li>Narendra Banik </li></ul><ul><li>Narayan Bhat </li></ul><ul><li>James Cook </li></ul><ul><li>William Tyor </li></ul><ul><li>Swapan Ray </li></ul><ul><li>Pediatrics </li></ul><ul><li>Inderjit Singh </li></ul><ul><li>Isabel Virella-Lowell </li></ul>
  12. 12. Program Faculty <ul><li>College of Dental Medicine </li></ul><ul><li>Robert Boackle </li></ul><ul><li>Caroline Westwater </li></ul><ul><li>Radiation Oncology </li></ul><ul><li>Sebastiano Gattoni-Celli </li></ul><ul><li>College of Pharmaceutical Sciences </li></ul><ul><li>Craig Beeson </li></ul><ul><li>Cell Biology & Anatomy </li></ul><ul><li>Titus Reaves </li></ul><ul><li>Rheumatology </li></ul><ul><li>James Oates </li></ul><ul><li>Maria Trojanowska </li></ul><ul><li>Gary Gilkeson </li></ul><ul><li>Biochemistry </li></ul><ul><li>Greg Warr </li></ul><ul><li>Maurizio Del Poeta </li></ul><ul><li>Division of Infectious Disease </li></ul><ul><li>Christopher Parsons </li></ul>
  13. 13. Entrepreneurship by M&I faculty Bacterial electricity generation, Microbial fuel cells Dr. May MFC Tech Therapeutic complement inhibitors Dr. Tomlinson Taligen Ceramide-modifying anti-cancer agents Dr. Norris SphingoGene Adenovirus-based subunit vaccines Dr. Dong GenPhar Technology Faculty Company
  14. 14. MOUNT PLEASANT, SC (AUGUST 30, 2007) - Groundbreaking ceremony for new facility at Innovation Park, in the economic development zone of The Market at Oakland. <ul><li>GenPhar, Inc. is a biopharmaceutical company dedicated to providing vaccines that protect against infectious diseases with great socio-economic impacts worldwide. </li></ul><ul><li>Biodefense programs: GenPhar's vaccine platform is ideally designed for biodefense because one vaccine can prevent infection from multiple virus subtypes. </li></ul>
  15. 15. James S. Norris, PhD Co-Founder, SphingoGene, Inc. http://www.sphingogene.com Professor and Chairman, MUSC [email_address] SphingoGene, Inc. SphingoGene, Inc. is focused on commercialization of small molecule therapeutics that modify ceramide metabolism to overcome resistance to chemo and radiation therapy and promote apoptosis in cancer cells. Ceramide is a “tumor suppressor sphingolipid” involved in regulation of cell death. SphingoGene, Inc.’s molecules are rationally designed and proven to inhibit enzymes that create resistance to conventional cancer therapies. Our goal is to utilize these small molecules in combination with “standard of care” radiation or chemotherapy to enhance cancer cell death. <ul><li>Commercial Lipidomic Services </li></ul><ul><li>Molecular diagnostic to predict patient </li></ul><ul><li>Response </li></ul><ul><li>Combination therapy for standard of care </li></ul><ul><li>Therapies in cancer patients (chemo, radiation and gene therapy </li></ul>Products and Services N H C O O H 1 2 O H (2S, 3R, 4E) D- erythro -Ceramide 3 4 5 n
  16. 16. Controlling Inflammation to Treat Human Disease Applying novel technologies to create better treatments Contact: Woodruff Emlen MD [email_address] Taligen Therapeutics, Inc. is a development stage biotechnology company with novel technology to modulate and regulate activation of the complement system. Inappropriate complement activation leading to inflammation is a major contributor to a large number of human diseases. Taligen has proof of concept data in animal models of diseases as diverse as asthma, macular degeneration, immune renal disease, inflammatory arthritis, ischemia-reperfusion injury, stroke and traumatic brain injury. Product Development Currently focused on the areas of asthma and age related macular degeneration. Stephen Tomlinson, PhD Professor [email_address]
  17. 17. Dr. Hal May, Ph.D. VP, MFC Technologies LLC http://www. mfctech .net hmay @ mfctech .net   Assoc. Prof. MUSC mayh @ musc . edu Microbially Generated Electricity Increase Biofuel Production 24/7 Remote Power, Sensor Control Control Waste, Odor and Algae
  18. 18. <ul><li>MFC Tech is focused on the development of microbial fuel cell technology (MFCs), which utilizes the ability of bacteria to generate electricity. </li></ul><ul><li>Patentable approaches are targeted for the enhancement of waste management and electricity generation, namely… </li></ul><ul><ul><li>24/7 remote power generation such as along highways and in retention ponds </li></ul></ul><ul><ul><li>Development of specific sensors or the powering of sensors in remote locations </li></ul></ul><ul><ul><li>Enhancement of biofuel production through the application of MFC technology to cellulosic ethanol fermentation </li></ul></ul><ul><ul><li>The reduction of agricultural waste, odors and algal blooms in waste lagoons and retention ponds </li></ul></ul>

×